Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic hepatocyte infusion product

Allogeneic human hepatocytes for infusion · Cytonet GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic hepatocyte infusion product, covering 2016-02-08 to 2016-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders [Phase 2]

See pricing